AKT1 and neoplasm: These experiments demonstrate that the inactivation of survival effector p-AKT leads to the rapid release of accumulated apoptotic potential in EGFR-addicted cancer cells, which may be an important reason that leads to the sensitivity of tumor cells to drugs that target the addicted oncogene EGFR.